Insider Transactions in Q3 2021 at Fate Therapeutics Inc (FATE)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 28
2021
|
Edward J Dulac Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,460
-27.08%
|
$1,206,520
$62.53 P/Share
|
Sep 28
2021
|
Edward J Dulac Iii Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,325
+19.43%
|
$606,375
$35.52 P/Share
|
Sep 13
2021
|
Bahram Valamehr Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
25,000
-7.31%
|
$1,650,000
$66.75 P/Share
|
Sep 13
2021
|
Bahram Valamehr Chief R&D Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.15%
|
$50,000
$2.73 P/Share
|
Aug 19
2021
|
Edward J Dulac Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,474
-2.03%
|
$305,712
$88.85 P/Share
|
Aug 19
2021
|
J Scott Wolchko President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-4.83%
|
$1,760,000
$88.01 P/Share
|
Aug 19
2021
|
J Scott Wolchko President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.61%
|
$80,000
$4.84 P/Share
|
Aug 03
2021
|
Yuan Xu |
BUY
Grant, award, or other acquisition
|
Direct |
4,744
+50.0%
|
-
|
Jul 23
2021
|
J Scott Wolchko President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-7.08%
|
$2,550,000
$85.28 P/Share
|
Jul 23
2021
|
J Scott Wolchko President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+3.46%
|
$90,000
$3.79 P/Share
|
Jul 22
2021
|
J Scott Wolchko President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-2.4%
|
$2,580,000
$86.16 P/Share
|
Jul 22
2021
|
J Scott Wolchko President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.61%
|
$60,000
$2.73 P/Share
|
Jul 01
2021
|
Cindy Tahl General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
55,534
-3.19%
|
$4,942,526
$89.97 P/Share
|
Jul 01
2021
|
Cindy Tahl General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
55,534
+8.61%
|
$333,204
$6.04 P/Share
|